Some researchers question whether these non-cyanocobalamin supplements are
stable in their oral form. For this reason, much larger amounts are typically
used with hope that at least some are absorbed intact. One study suggests that
once absorbed, methylcobalamin may be retained in the body better than
cyanocobalamin.30
…
The advantage using hydroxocobalamin is the lack of adverse effects seen with
the nitrites such as methemoglobinemia and hypotension. It works by exchanging
the hydroxy group for cyanide to form the non-toxic cyanocobalamin (vitamin
B12). …
The hydroxocobalamin neutralizes cyanide by fixing it to form cyanocobalamin
(vitamin B12) which is excreted in the urine. It does not have the problem of
reducing the blood’s capacity to carry oxygen as in the case of nitrite
administration. Hydroxocobalamin is red in color and will turn the mucous
membranes, skin, and urine red, which could interfere with clinical laboratory
tests which depend on color. …
The antitode used in Europe is hydroxocobalamin, a precursor to Vitamin B-12.
The drug is given intravenously and neutralizes cyanide to form cyanocobalamin,
Vitamin B-12, which the body expells by urination. …
The major classes of prescription drugs are failures. Most drugs are never
designed to address the underlying biochemical causes of disease — and they may
intentionally be designed to create life-long dependency. …
Olanzapine long-acting injection is an investigational formulation that combines
olanzapine, an atypical antipsychotic, with pamoic acid resulting in a salt that
sustains the delivery of olanzapine for a period of up to four weeks.
Long-acting injectables have been associated with improved treatment for
patients who struggle with adherence to oral medications.(i) …
The lawsuit alleges that “Merck’s costly promotional campaign was intended to
convince purchasers that the drug was not only safe, but that they should demand
it from their healthcare professionals for pain treatment,” according to a
statement from the attorney general. …
Extensive clinical testing would be needed to draw conclusions about the safety
of TOFA and C75, or similar compounds, as antiviral treatment. That said, the
team took an early look at toxicity, exposing uninfected fibroblasts to C75 or
TOFA for 96 hours. They found that the drugs blocked HCMV replication without
causing cell toxicity or self-destruction (apoptosis). …
“Our results suggest the genetic make-up of patients could predispose their
responsiveness to a drug. This could have important implications for the future
of personalized molecular-based or individualized medicine,” …
Statistics show ZERO improvement in lifespan or quality of life for about 98% of
patients receiving chemotherapy. Only a very small number of people suffering
rare forms of cancer have any documented benefits from the often-deadly
procedure. …